Similar articles

• Biosynthesis of the heat-shock protein 90 inhibitor geldanamycin: new insight into the formation of the benzoquinone moiety.

  Lee D, Lee K, Cai XF, Dat NT, Boovanahalli SK, Lee M, Shin JC, Kim W, Jeong JK, Lee JS, Lee CH, Lee JH, Hong YS, Lee JJ. Lee D, et al. Chembiochem. 2006 Feb;7(2):246-8. doi: 10.1002/cbic.200500441. Chembiochem. 2006. PMID: 16381049 No abstract available.
• [Hsp90: how a chaperone becomes a pharmacological target].

  Jacquemin-Sablon A. Jacquemin-Sablon A. Bull Cancer. 2003 Nov;90(11):935-6. Bull Cancer. 2003. PMID: 14706894 French. No abstract available.
• Structural basis for inhibition of the Hsp90 molecular chaperone by the antitumor antibiotics radicicol and geldanamycin.

  Roe SM, Prodromou C, O'Brien R, Ladbury JE, Piper PW, Pearl LH. Roe SM, et al. J Med Chem. 1999 Jan 28;42(2):260-6. doi: 10.1021/jm980403y. J Med Chem. 1999. PMID: 9925731
• Geldanamycin: the prototype of a class of antitumor drugs targeting the heat shock protein 90 family of molecular chaperones.

  Ochel HJ, Eichhorn K, Gademann G. Ochel HJ, et al. Cell Stress Chaperones. 2001 Apr;6(2):105-12. doi: 10.1379/1466-1268(2001)006<0105:gtpoac>2.0.co;2. Cell Stress Chaperones. 2001. PMID: 11599571 Free PMC article. Review. No abstract available.
• [Heat shock protein 90: novel target for cancer therapy].

  Chen Y, Ding J. Chen Y, et al. Ai Zheng. 2004 Aug;23(8):968-74. Ai Zheng. 2004. PMID: 15301726 Review. Chinese.